5 Healthcare dividend stocks rated Buy or better (Nov 2026)
5 Healthcare dividend stocks rated Buy or better by the Lician Quant rating as of Nov 4, 2026, including UnitedHealth Group Incorporated (UNH), Amgen Inc (AMGN), GlaxoSmithKline PLC ADR (GSK). Dividend yield of 2% or more (EODHD fundamentals) and a Buy or Strong Buy rating.
Open this screen in the full screener to add filters, sort by any factor and save it.
5 stocks · Strong Buy or Buy · Healthcare · Dividend yield ≥ 2%
| Stock | Quant ratingRating | ValuationVal | GrowthGrow | ProfitabilityProf | MomentumMom | EPS revisionsRev | Market capMkt cap | P/EP/E | Revenue growthRev YoY | Div. yieldYield | Short % floatShort | Next earningsEarnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1GSKGlaxoSmithKline PLC ADR | 4.72Strong Buy | A | B | A | C- | — | $99.3B | 13.2 | +7.4% | 3.50% | 0.4% | — |
| 2NRCNational Research Corp | 4.42Buy | B- | C | A- | A+ | C+ | $452M | 77.2 | -0.2% | 3.03% | — | — |
| 3AMGNAmgen Inc | 4.76Strong Buy | B | B- | A+ | A | C+ | $250B | 28.6 | +9.1% | 2.80% | 2.5% | — |
| 4CICigna Corp | 4.03Buy | A+ | B- | B- | B- | D | $78.2B | 12.2 | +7.8% | 2.23% | 2.6% | Nov 5 |
| 5UNHUnitedHealth Group Incorporated | 4.35Buy | A | C- | A- | B- | B | $364B | 25.8 | +6.5% | 2.17% | — | — |
Source: Lician Quant Grades (SEC EDGAR statements, EODHD prices and estimates); short interest: FINRA; earnings dates: earnings calendar; dividend yield: EODHD fundamentals · Quant run Nov 4, 2026
Grades rank each stock against its sector peers; they are not investment advice. How the rating and grades work · Short interest · Earnings calendar
Dividend 2%+ in other sectors
About this screen
- Which are the top Healthcare dividend stocks rated Buy or better?
- As of Nov 4, 2026, the highest ranked are GlaxoSmithKline PLC ADR (GSK, rating 4.72); National Research Corp (NRC, rating 4.42); Amgen Inc (AMGN, rating 4.76); Cigna Corp (CI, rating 4.03); UnitedHealth Group Incorporated (UNH, rating 4.35). 5 stocks pass the screen in total.
- What does this screen look for?
- Dividend yield of 2% or more (EODHD fundamentals) and a Buy or Strong Buy rating.
- How is the Lician Quant rating calculated?
- Each stock gets five factor grades (Valuation, Growth, Profitability, Momentum, EPS Revisions) from A+ to F by ranking its metrics against the other stocks in its sector. The rating (1.00 to 5.00) is the equal-weight average of the factor scores, re-ranked within the sector: 4.50 and up is Strong Buy, 3.50 Buy, 2.50 Hold, 1.50 Sell, below that Strong Sell.
- How often is the list updated?
- After every US trading day, from SEC filings, EODHD prices and analyst estimates; this list is from the quant run of Nov 4, 2026. Short interest follows FINRA's twice-monthly settlement dates.